An Exploratory Crossover Clinical Trial to Compare the Activity of Reproxalap and Lifitegrast in a Dry Eye Disease Chamber
Clinical trial NCT05102409 · COMPLETED
Trial details
- NCT number
- NCT05102409
- Sponsor
- Aldeyra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-09
- Primary completion
- 2021-10-25
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.